Before joining Turenne Capital in 2014, Bervin Bouani spent six years as an Asset Manager within the investment department at SHAM, an insurer specialized in healthcare companies’ risks. At SHAM, Bervin was in charge of risky assets (listed equities, Hedge Funds and private equity) and was in particular involved in the development of the private equity business (€ 30 million invested in 15 companies, including Adocia, Biomup, Voluntis). Bervin began his career as a junior financial engineer at CM-CIC. Bervin holds a Master’s degree in Markets and Corporate Finance from Université Catholique de Lille. Bervin is responsible for the HalioDx, CarThera, Brainever, Orega Biotech and Antabio holdings.